Tech Company Financing Transactions
MANA Therapeutics Funding Round
On 1/11/2021, MANA Therapeutics raised $35 million in Series A financing from Cobro Ventures, Lightchain and LifeSci Venture Partners.
Transaction Overview
Company Name
Announced On
1/11/2021
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1000 Wilson Blvd. 1800
Arlington, VA 22209
USA
Arlington, VA 22209
USA
Phone
Undisclosed
Website
Email Address
Overview
Our name, MANA, is a word from the Maori culture where it is believed that one's "Mana," a force that drives leadership, character and influence, is strengthened by helping and caring for others. This sentiment inspires us and drives how we are building our company and caring for our patients, the healthcare community, employees, partners and collaborators.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Silverstein
Chief Technical Officer
Madhusudan Peshwa
Vice President
Tunç Toker
VP - Operations
Barb Geiger
VP - R & D
Arthur Hurwitz
VP - Regulatory Affairs
Michael Kuo
Browse more venture capital transactions:
Prev: 1/11/2021: NCX venture capital transaction
Next: 1/11/2021: Voxie venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs